Sanofi-Aventis Must Allow News Site To Use Drug Name

Law360, New York (November 14, 2005, 12:00 AM EST) -- French pharmaceutical giant Sanofi-Aventis Group Inc. failed in federal court to stop a publisher from using the name of its yet-to-be-approved obesity drug in a news website’s address.

Medical Week News Inc. sued Sanofi Aventis in June, seeking declaratory judgment that a website owned by the news organization does not infringe the drug maker’s trademark for Acomplia. The suit was filed in the U.S. District Court for the Northern District of California.

The settlement allows the website to keep its domain name as long as there...
To view the full article, register now.